These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 9224413)
21. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245 [TBL] [Abstract][Full Text] [Related]
22. Effects of combined immune therapy on survival and Th1/Th2 cytokine balance in rat orthotopic liver transplantation. Cao H; Liu H; Wu ZY Chin Med J (Engl); 2007 Oct; 120(20):1809-12. PubMed ID: 18028776 [TBL] [Abstract][Full Text] [Related]
23. Effect of early cyclosporine levels on kidney allograft rejection. Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683 [TBL] [Abstract][Full Text] [Related]
24. Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: lipid lowering and immunosuppression. Katznelson S; Kobashigawa JA Kidney Int Suppl; 1995 Dec; 52():S112-5. PubMed ID: 8587272 [TBL] [Abstract][Full Text] [Related]
25. Significant prolongation of animal survival by combined therapy of FR167653 and cyclosporine A in rat renal allografts. Azuma H; Wada T; Gotoh R; Furuichi K; Sakai N; Yazawa K; Yokoyama H; Katsuoka Y; Takahara S Transplantation; 2003 Oct; 76(7):1029-36. PubMed ID: 14557748 [TBL] [Abstract][Full Text] [Related]
26. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation]. Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420 [TBL] [Abstract][Full Text] [Related]
27. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model. Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747 [TBL] [Abstract][Full Text] [Related]
28. Effects of pravastatin on chronic rejection of rat cardiac allografts. Maggard MA; Ke B; Wang T; Kaldas F; Seu P; Busuttil RW; Imagawa DK Transplantation; 1998 Jan; 65(2):149-55. PubMed ID: 9458006 [TBL] [Abstract][Full Text] [Related]
29. Prevention of chronic rejection by pravastatin in a rat kidney transplant model. Ji P; Si MS; Podnos Y; Chow H; Steward E; Imagawa DK Transplantation; 2002 Sep; 74(6):821-7. PubMed ID: 12364863 [TBL] [Abstract][Full Text] [Related]
30. The effect of pravastatin on acute rejection after kidney transplantation--a pilot study. Katznelson S; Wilkinson AH; Kobashigawa JA; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Cohen AH; Teraski PI Transplantation; 1996 May; 61(10):1469-74. PubMed ID: 8633373 [TBL] [Abstract][Full Text] [Related]
31. Effect of pravastatin, a potent 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on survival of AH130 hepatoma-bearing rats. Kawata S; Kakimoto H; Ishiguro H; Yamasaki E; Inui Y; Matsuzawa Y Jpn J Cancer Res; 1992 Nov; 83(11):1120-3. PubMed ID: 1483925 [TBL] [Abstract][Full Text] [Related]
32. Impairment of peroxisomal structure and function in rat liver allograft rejection: prevention by cyclosporine. Steinmetz I; Weber T; Beier K; Czerny F; Kusterer K; Hanisch E; Völkl A; Fahimi HD; Angermüller S Transplantation; 1998 Jul; 66(2):186-94. PubMed ID: 9701262 [TBL] [Abstract][Full Text] [Related]
33. Identification of a natural killer enhancing factor (NKEF) from human erythroid cells. Shau H; Gupta RK; Golub SH Cell Immunol; 1993 Mar; 147(1):1-11. PubMed ID: 8462106 [TBL] [Abstract][Full Text] [Related]
34. [Effect of 3-hydroxy-3-methylglutaryl coenzyme A(HMG-CoA) reductase inhibitor, pravastatin on liver metastasis of a pancreatic cancer cell line, SUIT-2 in nude mice]. Shimazoe T; Kono A; Funakoshi A Gan To Kagaku Ryoho; 1994 Jun; 21(7):1077-9. PubMed ID: 8002625 [No Abstract] [Full Text] [Related]
35. Effect of pravastatin on outcomes after cardiac transplantation. Kobashigawa JA; Katznelson S; Laks H; Johnson JA; Yeatman L; Wang XM; Chia D; Terasaki PI; Sabad A; Cogert GA N Engl J Med; 1995 Sep; 333(10):621-7. PubMed ID: 7637722 [TBL] [Abstract][Full Text] [Related]
36. Cloning and sequence analysis of candidate human natural killer-enhancing factor genes. Shau H; Butterfield LH; Chiu R; Kim A Immunogenetics; 1994; 40(2):129-34. PubMed ID: 8026862 [TBL] [Abstract][Full Text] [Related]
37. HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family. Geiben-Lynn R; Kursar M; Brown NV; Addo MM; Shau H; Lieberman J; Luster AD; Walker BD J Biol Chem; 2003 Jan; 278(3):1569-74. PubMed ID: 12421812 [TBL] [Abstract][Full Text] [Related]
38. Cloning, characterization and genomic structure of the natural killer cell enhancement factor (NKEF)-like gene from homozygous clones of rainbow trout (Oncorhynchus mykiss). Zhang H; Evenhuis JP; Thorgaard GH; Ristow SS Dev Comp Immunol; 2001 Jan; 25(1):25-35. PubMed ID: 10980317 [TBL] [Abstract][Full Text] [Related]
39. Expression of the antioxidant gene NKEF in the central nervous system. Sarafian TA; Huang C; Kim A; de Vellis J; Shau H Mol Chem Neuropathol; 1998 May; 34(1):39-51. PubMed ID: 9778645 [TBL] [Abstract][Full Text] [Related]
40. Antioxidant function of recombinant human natural killer enhancing factor. Sauri H; Butterfield L; Kim A; Shau H Biochem Biophys Res Commun; 1995 Mar; 208(3):964-9. PubMed ID: 7702627 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]